Cascade Screening in Familial Hypercholesterolemia: Achieving Buy-In and Turning Patients Into Partners

Overview

Journal CJC Pediatr Congenit Heart Dis

Specialty Cardiology & Vascular Diseases

Date 2023 Nov 16

PMID 37970215

Authors

Michael Khoury

Affiliations

Soon will be listed here.

References

Nordestgaard B, Chapman M, Humphries S, Ginsberg H, Masana L, Descamps O . Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34(45):3478-90a. PMC: 3844152. DOI: 10.1093/eurheartj/eht273. View

Wald D, Bestwick J . Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies. Atherosclerosis. 2019; 293:57-61. DOI: 10.1016/j.atherosclerosis.2019.11.028. View

Wiegman A, Gidding S, Watts G, Chapman M, Ginsberg H, Cuchel M . Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015; 36(36):2425-37. PMC: 4576143. DOI: 10.1093/eurheartj/ehv157. View

Dickson M, Zahavich L, Rush J, Hewson S, Chitayat D, McCrindle B . Exploring Barriers and Facilitators to Indirect Cascade Screening for Familial Hypercholesteraemia in a Paediatric/Parent Population. CJC Pediatr Congenit Heart Dis. 2023; 2(5):211-218. PMC: 10642093. DOI: 10.1016/j.cjcpc.2023.05.006. View

. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128 Suppl 5:S213-56. PMC: 4536582. DOI: 10.1542/peds.2009-2107C. View

McKay A, Hogan H, Humphries S, Marks D, Ray K, Miners A . Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis. Atherosclerosis. 2018; 275:434-443. DOI: 10.1016/j.atherosclerosis.2018.05.047. View

Khoury M, McCrindle B . The Rationale, Indications, Safety, and Use of Statins in the Pediatric Population. Can J Cardiol. 2020; 36(9):1372-1383. DOI: 10.1016/j.cjca.2020.03.041. View

Luirink I, Wiegman A, Kusters D, Hof M, Groothoff J, de Groot E . 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia. N Engl J Med. 2019; 381(16):1547-1556. DOI: 10.1056/NEJMoa1816454. View

Brunham L, Ruel I, Aljenedil S, Riviere J, Baass A, Tu J . Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018. Can J Cardiol. 2018; 34(12):1553-1563. DOI: 10.1016/j.cjca.2018.09.005. View

10.

Sturm A, Knowles J, Gidding S, Ahmad Z, Ahmed C, Ballantyne C . Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018; 72(6):662-680. DOI: 10.1016/j.jacc.2018.05.044. View

11.

Berenson G, Srinivasan S, Bao W, Newman 3rd W, Tracy R, Wattigney W . Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998; 338(23):1650-6. DOI: 10.1056/NEJM199806043382302. View

12.

Vuorio A, Kuoppala J, Kovanen P, Humphries S, Tonstad S, Wiegman A . Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2019; 2019(11). PMC: 6836374. DOI: 10.1002/14651858.CD006401.pub5. View

13.

Ruel I, Brisson D, Aljenedil S, Awan Z, Baass A, Belanger A . Simplified Canadian Definition for Familial Hypercholesterolemia. Can J Cardiol. 2018; 34(9):1210-1214. DOI: 10.1016/j.cjca.2018.05.015. View

14.

Khoury M, Rodday A, Mackie A, Gill P, McLaughlin T, Harris K . Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers. Can J Cardiol. 2020; 36(9):1545-1549. DOI: 10.1016/j.cjca.2020.05.035. View

15.

Wald D, Bestwick J, Morris J, Whyte K, Jenkins L, Wald N . Child-Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med. 2016; 375(17):1628-1637. DOI: 10.1056/NEJMoa1602777. View

16.

Khoury M, Bigras J, Cummings E, Harris K, Hegele R, Henderson M . The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update. Can J Cardiol. 2022; 38(8):1168-1179. DOI: 10.1016/j.cjca.2022.05.002. View